智慧霧化器市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、最終用戶、地區和競爭對手分類，2021-2031年

全球智慧霧化器市場預計將從 2025 年的 3.7102 億美元大幅成長至 2031 年的 7.6795 億美元，複合年成長率將達到 12.89%。

這些先進的數位醫療設備不僅能將液體藥物轉化為可吸入氣霧劑，還獨特地整合了無線連接功能，可透過整合的行動應用程式監測患者的治療依從性和呼吸生命徵象。這一市場擴張的主要驅動力是全球慢性呼吸系統疾病（如氣喘和慢性阻塞性肺病(COPD)）的盛行率不斷上升，這些疾病迫切需要精準的管理工具。此外，醫療保健系統中遠端醫療和遠端患者監護的日益普及也促進了這一成長，使醫護人員能夠有效地監督治療依從性並最佳化患者療效。

然而，該領域的發展仍面臨許多重大障礙。與傳統霧化器相比，智慧霧化器較高的購置成本阻礙了其在價格敏感地區的普及。這一經濟壁壘限制了其廣泛應用。同時，大量患者需要有效且長期的呼吸系統照護。例如，歐洲呼吸學會的報告指出，到2025年，歐洲約有8,170萬人將患有慢性呼吸系統疾病，凸顯了對擴充性、價格合理且先進的治療方案的迫切需求。

市場促進因素

全球智慧霧化器市場成長的主要驅動力是全球慢性呼吸系統疾病盛行率的不斷上升。隨著氣喘和慢性阻塞性肺病（COPD）的發生率在全球範圍內持續攀升，人們對旨在預防急性發作的有效家庭療法的需求也隨之激增。空氣污染加劇和都市化等環境因素進一步強化了這個市場勢頭，這些因素常常引發需要持續管理和精準用藥的呼吸系統疾病。根據Omron Corporation發布的《2024年綜合報告》，其呼吸系統業務在2023會計年度的銷售額達到1497億日元，主要得益於呼吸系統疾病流行導致霧化器需求的成長。同時，美國氣喘與過敏基金會（AAFA）發布的《2024年氣喘之都報告》指出，約有2,800萬美國人患有氣喘，這為先進醫療設備的普及應用奠定了堅實的基礎。

同時，物聯網和數位健康連接的融合正在改變市場格局，設備正演進為用於全面疾病管理的智慧平台。智慧霧化器正利用這種連結性，透過精準追蹤用藥依從性和改進吸入技術，直接解決傳統的依從性難題。這項進步與更廣泛的醫療保健趨勢（例如遠端監測）完美契合，使醫療服務提供者能夠利用即時數據主動干預並提供個人化護理。根據瑞思邁公司 (ResMed Inc.) 2024 年年度報告，其軟體即服務 (SaaS) 營收年增 10%。這凸顯了支持互聯呼吸護理並提升臨床效用的數位健康生態系統的擴展，也解釋了智慧設備價格上漲的合理性並推動了市場滲透。

市場挑戰

全球智慧霧化器市場的擴張受到其高昂購置成本的顯著限制，而這些先進設備的價格遠高於傳統霧化器。智慧霧化器整合了數位感測器、藍牙連接模組和內建可充電電源系統等先進組件，這些都不可避免地推高了製造成本和零售價格。這種巨大的價格差異構成了市場准入的主要障礙，尤其是在價格敏感型市場。在這些市場，醫療預算往往有限，患者經常需要自付高額費用，因此，對於優先考慮基本藥物而非昂貴給藥技術的低度開發地區和低收入群體而言，智慧霧化器的普及受到限制。

近期的數據進一步印證了呼吸系統疾病患者的經濟負擔。美國肺臟協會在2024年報告稱，氣喘藥物處方箋的平均年度醫療費用達到每人1,830美元，這意味著大約四分之一的成年人將難以負擔這些費用。現有治療方法如此高昂的基本成本使得許多人難以再投資購買昂貴的智慧型設備，因此，儘管智慧霧化器具有功能優勢，但價格更親民的傳統霧化器仍然更受青睞，這限制了智慧霧化器的整體市場潛力。

市場趨勢

推動市場變革的關鍵趨勢之一是智慧霧化器與遠端患者監護(RPM) 平台的融合，這使得市場關注點從簡單的藥物輸送轉向全面的呼吸照護管理。設備製造商正日益將連接功能融入產品，以便將用藥依從性和肺功能數據即時傳輸到臨床工作流程中，從而使醫療專業人員能夠主動干預並實現個人化治療。數位監測服務報銷代碼的擴展進一步推動了這一融合，有效加速了互聯醫療生態系統的普及。皇家飛利浦 2024 年年度報告顯示，其互聯醫療業務部門的同業收入年增 2%，這主要得益於其涵蓋呼吸資訊學和監測的企業級數位健康平台的擴展。

同時，為因應日益成長的監管壓力和更廣泛的醫療保健永續性目標，製造商正陸續推出環保且永續的醫療器材材料，其市場佔有率顯著成長。一場策略轉型正在進行，從一次性、不可回收塑膠轉向生物基聚合物和模組化設計，積極支持維修舉措和循環經濟模式。這項轉型不僅有助於解決醫療廢棄物對環境的巨大影響，也深受具有環保意識的醫療機構和患者的青睞。皇家飛利浦2024年年度報告進一步指出，集團總收入的24%來自循環產品和服務，凸顯了醫療技術和呼吸照護領域對永續發展日益成長的商業性需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球智慧霧化器市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（可攜式智慧霧化器、手持式智慧霧化器、桌上型智慧霧化器）
  • 依應用領域（慢性阻塞性肺病（COPD）、囊腫纖維化、氣喘、其他）
  • 依最終使用者（醫院/診所、急診中心、居家醫療）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美智慧霧化器市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲智慧霧化器市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區智慧霧化器市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲智慧霧化器市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲智慧霧化器市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球智慧霧化器市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Koninklijke Philips NV
• Omron Healthcare, Inc.
• PARI GmbH
• Drive DeVilbiss Healthcare, Inc.
• Medtronic plc
• Flaem Nuova SpA
• Trudell Medical International
• Vectura Group plc
• GF Health Products, Inc.
• Aerogen Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Smart Nebulizers Market is projected to expand significantly, growing from USD 371.02 Million in 2025 to USD 767.95 Million by 2031, demonstrating a 12.89% Compound Annual Growth Rate. These advanced digital medical devices transform liquid medication into an aerosol for inhalation, uniquely incorporating wireless connectivity to monitor patient adherence and vital respiratory metrics through linked mobile applications. This market expansion is predominantly fueled by the increasing worldwide incidence of chronic respiratory conditions like asthma and chronic obstructive pulmonary disease, which urgently require precise management tools. Further supporting this growth is the increasing adoption of telemedicine and remote patient monitoring within healthcare systems, enabling medical professionals to effectively oversee treatment compliance and optimize patient outcomes.

However, the growth of this sector faces a notable obstacle: the elevated acquisition cost of smart nebulizers compared to their traditional counterparts, which hinders their uptake in regions sensitive to pricing. This financial impediment limits widespread access, even though a substantial patient population requires effective long-term respiratory care. For instance, the European Respiratory Society reported that in 2025, approximately 81.7 million individuals across Europe were affected by chronic respiratory diseases, underscoring the critical need for scalable yet affordable advanced therapeutic solutions.

Market Driver

The primary catalyst for growth in the Global Smart Nebulizers Market is the escalating prevalence of chronic respiratory conditions worldwide. As rates of asthma and COPD continue to rise globally, there's a corresponding surge in demand for effective home-based therapies designed to prevent acute exacerbations. This market momentum is further intensified by environmental factors, such as increased pollution and urbanization, which frequently trigger respiratory ailments necessitating consistent management and precise drug delivery. Omron Corporation's 'Integrated Report 2024' highlighted that its respiratory business achieved net sales of 149.7 billion JPY in fiscal 2023, largely propelled by the growing demand for nebulizers amid respiratory outbreaks, while the Asthma and Allergy Foundation of America's '2024 Asthma Capitals' report indicated nearly 28 million Americans live with asthma, solidifying a substantial base for advanced device adoption.

Concurrently, the integration of IoT and digital health connectivity is profoundly transforming the market by evolving devices into intelligent platforms for comprehensive disease management. Smart nebulizers now leverage this connectivity to accurately track medication adherence and refine inhalation techniques, directly addressing historical compliance challenges. This development aligns seamlessly with the broader healthcare trend towards remote monitoring, where real-time data empowers providers to intervene proactively and tailor care. ResMed Inc.'s 'Annual Report 2024' reported a 10% year-over-year increase in Software as a Service (SaaS) revenue, underscoring the expanding digital health ecosystems that underpin connected respiratory care and enhance the clinical utility, thereby justifying the premium pricing of smart devices and fostering greater market penetration.

Market Challenge

The Global Smart Nebulizers Market's expansion is considerably impeded by the high acquisition cost of these advanced devices when compared to conventional alternatives. Smart nebulizers incorporate sophisticated components such as digital sensors, Bluetooth connectivity modules, and integrated rechargeable power systems, all of which inevitably inflate their manufacturing and subsequent retail prices. This significant price difference establishes a substantial barrier to entry, particularly in price-sensitive markets where healthcare budgets are often restricted and patients frequently face considerable out-of-pocket expenses, thereby limiting adoption rates in developing regions and among lower-income demographics who prioritize essential medication over premium drug delivery technology.

This financial strain is further corroborated by recent data illustrating the economic burden on respiratory patients. The American Lung Association reported in 2024 that the annual per-person medical cost for asthma prescriptions alone was $1,830, with approximately one in four adults struggling to afford these expenses. Such elevated baseline costs for existing treatment make the additional investment in expensive smart devices prohibitive for many individuals, consequently restricting the market's overall potential as a widespread preference for more affordable, conventional nebulizers persists despite the functional advantages offered by smart alternatives.

Market Trends

A defining trend transforming the market is the integration of smart nebulizers with Remote Patient Monitoring (RPM) platforms, shifting focus from mere drug delivery to comprehensive respiratory care management. Device manufacturers are increasingly incorporating connectivity features that transmit real-time adherence and lung function data directly into clinical workflows, enabling healthcare providers to intervene proactively and personalize treatments. This convergence is further propelled by the expansion of reimbursement codes for digital monitoring services, which effectively incentivizes the adoption of interconnected care ecosystems. Royal Philips' 'Annual Report 2024' highlighted a 2% comparable sales increase year-over-year in its Connected Care business segment, largely driven by the scaling of its enterprise digital health platforms that encompass respiratory informatics and monitoring.

Simultaneously, the market is experiencing a notable emergence of eco-friendly and sustainable device materials, as manufacturers respond to escalating regulatory pressures and broader healthcare sustainability objectives. There is a strategic transition away from single-use, non-recyclable plastics towards bio-based polymers and modular designs, which actively support refurbishment initiatives and circular economy models. This shift not only addresses the significant environmental impact of medical waste but also appeals strongly to environmentally conscious institutional buyers and individual patients. Royal Philips' 'Annual Report 2024' further reported that 24% of its total group revenues were generated from circular products and services, emphasizing the growing commercial imperative of sustainability within the medical technology and respiratory care sectors.

Key Market Players

• Koninklijke Philips N.V.
• Omron Healthcare, Inc.
• PARI GmbH
• Drive DeVilbiss Healthcare, Inc.
• Medtronic plc
• Flaem Nuova S.p.A.
• Trudell Medical International
• Vectura Group plc
• GF Health Products, Inc.
• Aerogen Ltd.

Report Scope

In this report, the Global Smart Nebulizers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Smart Nebulizers Market, By Type

• Portable Smart Nebulizers
• Handheld Smart Nebulizers
• Table-top Smart Nebulizers

Smart Nebulizers Market, By Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Cystic Fibrosis
• Asthma
• Others

Smart Nebulizers Market, By End-User

• Hospitals & Clinics
• Emergency Centers
• Home Healthcare

Smart Nebulizers Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Smart Nebulizers Market.

Available Customizations:

Global Smart Nebulizers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Smart Nebulizers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Portable Smart Nebulizers, Handheld Smart Nebulizers, Table-top Smart Nebulizers)
  • 5.2.2. By Application (Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Asthma, Others)
  • 5.2.3. By End-User (Hospitals & Clinics, Emergency Centers, Home Healthcare)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Smart Nebulizers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Smart Nebulizers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Smart Nebulizers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Smart Nebulizers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-User

7. Europe Smart Nebulizers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Smart Nebulizers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-User
  • 7.3.2. France Smart Nebulizers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-User
  • 7.3.3. United Kingdom Smart Nebulizers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Smart Nebulizers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Smart Nebulizers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-User

8. Asia Pacific Smart Nebulizers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Smart Nebulizers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Smart Nebulizers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Smart Nebulizers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Smart Nebulizers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Smart Nebulizers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-User

9. Middle East & Africa Smart Nebulizers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Smart Nebulizers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-User
  • 9.3.2. UAE Smart Nebulizers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-User
  • 9.3.3. South Africa Smart Nebulizers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-User

10. South America Smart Nebulizers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Smart Nebulizers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-User
  • 10.3.2. Colombia Smart Nebulizers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-User
  • 10.3.3. Argentina Smart Nebulizers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Smart Nebulizers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Koninklijke Philips N.V.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Omron Healthcare, Inc.
• 15.3. PARI GmbH
• 15.4. Drive DeVilbiss Healthcare, Inc.
• 15.5. Medtronic plc
• 15.6. Flaem Nuova S.p.A.
• 15.7. Trudell Medical International
• 15.8. Vectura Group plc
• 15.9. GF Health Products, Inc.
• 15.10. Aerogen Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer